| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PASG | Passage BIO, Inc. | Chief Operating Officer | $339K | Dec 8, 2021 | ||
| TERN | Terns Pharmaceuticals, Inc. | Director | $0 | -$86.5K | -100% | Jun 11, 2025 |
| CMMB | Chemomab Therapeutics Ltd. | Director | Jun 16, 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|